Actionable genomic information for accurate diagnosis for metastatic patients with diagnostic ambiguity.
An accurate tumor type diagnosis is the first step in precision oncology.
Highlights:
Distinguishes between 50 tumor types
Identifies tumor types not previously considered
Most widely adopted gene expression test for diagnosis of unknown or uncertain tumors
Requires small tumor sample (~300 cells)
Treatment recommendations changed in 47% of patients based on incorporation of test results (more)^
Test results available within 5 business days
(from receipt of specimen and required information)
Most validated gene expression test
100% covered by Medicare
Helping 7,500 physicians and 32,000 metastatic patients for over 8 years
CancerTYPE ID: Mechanism of Action
The Most Important Aspect to Treating Tumors
^ NeoTYPE Cancer Profiles are performed and billed separately by our contracted reference laboratory, NeoGenomics Laboratories, Inc.
